Preblick Ryan bought INDV
March 3, 2026 · Form 4 insider transaction
Preblick Ryan bought 86,949 shares of Indivior Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
86,949
Price
N/A
Total value
N/A
InsiderPreblick Ryan
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after317,292
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period.; Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.